Clincosm LogoSign in Get a demo

MDS

Showing 26 - 50 of 108
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in France (transplantation)

Active, not recruiting
  • MDS
  • transplantation
  • Amiens, France
  • +36 more
Jul 4, 2022

Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Fedratinib Pill
  • Tampa, Florida
    Moffitt Cancer Center
Jun 15, 2022

MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)

Recruiting
  • MDS
  • Myelodysplastic Syndromes
  • Luspatercept Injection [Reblozyl]
  • Eprex
  • Amiens, France
  • +30 more
May 19, 2022

AML, B-ALL, T-ALL Trial in Memphis (CD123-CAR T, Cyclophosphamide, Fludarabine)

Recruiting
  • AML
  • +4 more
  • CD123-CAR T
  • +4 more
  • Memphis, Tennessee
  • +1 more
May 10, 2022

AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

Recruiting
  • AML
  • +8 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 13, 2022

Familial Investigations of Childhood Cancer Predisposition

Recruiting
  • Acute Leukemia
  • +45 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    May 11, 2022

    Relapsed/Refractory AML, AML, Adult, MDS Trial in United States (NKX101 - CAR NK cell therapy)

    Recruiting
    • Relapsed/Refractory AML
    • +3 more
    • NKX101 - CAR NK cell therapy
    • Denver, Colorado
    • +6 more
    Apr 8, 2022

    AML, MDS Trial in Tianjin (SHR-1702)

    Active, not recruiting
    • AML
    • MDS
    • Tianjin, Tianjin, China
      Blood disease hospital of Chinese Academy of Medical Sciences
    Mar 7, 2022

    AML, Adult Recurrent, MDS Trial in Durham (DVX201)

    Recruiting
    • AML, Adult Recurrent
    • MDS
    • DVX201
    • Durham, North Carolina
      Duke University Hospital
    Feb 11, 2022

    AML, MDS Trial in United States (APVO436)

    Recruiting
    • AML
    • MDS
    • APVO436
    • San Francisco, California
    • +11 more
    Feb 8, 2022

    MDS Trial in New Haven (CPX-351)

    Withdrawn
    • MDS
    • New Haven, Connecticut
      Yale University; Smilow Cancer Center
    Jan 6, 2022

    National Longitudinal Cohort of Hematological Diseases

    Recruiting
    • Multiple Myeloma
    • +17 more
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Jan 11, 2022

      Optimize Treatment Strategies for Older Hematologic Malignancies

      Recruiting
      • Leukemia, Acute
      • MDS
      • Bone Marrow or Peripheral Blood Graft (BMT)
      • +2 more
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Jan 7, 2022

      AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

      Recruiting
      • AML
      • +3 more
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Dec 27, 2021

      Acute Myelogenous Leukemia, AML, Advanced MDS Trial in Miami (Pevonedistat, Cytarabine)

      Completed
      • Acute Myelogenous Leukemia
      • +3 more
      • Miami, Florida
        University of Miami
      Dec 7, 2021

      Leukemia, Lymphoma, Multiple Myeloma Trial in Omaha (CHAMPS-II adapted to adults 60+ years in HCT setting, Survivorship

      Recruiting
      • Leukemia
      • +4 more
      • CHAMPS-II adapted to adults 60+ years in HCT setting
      • Survivorship education active control
      • Omaha, Nebraska
        University of Nebraska Medical Center
      Nov 26, 2021

      MDS Trial in France (Decitabine, HYDROXYUREA)

      Completed
      • MDS
      • Saint-Denis, La Réunion, France
      • +44 more
      Nov 17, 2021

      GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

      Recruiting
      • GVHD
      • +15 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Sep 30, 2021

      MDS Trial in Beijing (Hetrombopag, Stanozolol Tablets)

      Not yet recruiting
      • MDS
      • Beijing, China
        Peking Union Medical College Hospital
      Sep 18, 2021

      AML, Adult, MDS Trial in Lørenskog (Standard therapy, Precision therapy)

      Recruiting
      • AML, Adult
      • MDS
      • Standard therapy
      • Precision therapy
      • Lørenskog, Norway
        Akershus Universitetssykehus
      Aug 23, 2021

      AML, ALL, MDS Trial in Germany (Peripheral blood stem cells)

      Recruiting
      • AML
      • +2 more
      • Peripheral blood stem cells
      • Bonn, Germany
      • +8 more
      Aug 25, 2021

      Optical Genome Mapping in Hematological Malignancies

      Recruiting
      • MDS
      • +2 more
        • Brest, France
        • +3 more
        Aug 16, 2021

        AML, MDS Trial in Belgium, United States (NKR-2)

        Completed
        • AML
        • MDS
        • NKR-2
        • Aurora, Colorado
        • +6 more
        Apr 30, 2021

        P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

        Recruiting
        • P53 Mutation
        • +3 more
        • Shanghai, Shanghai, China
          Hematological department, Shanghai Institute of Hematology, Ruij
        Apr 20, 2021

        MDS, CMML, AML Trial in Canada, United States (SGI-110)

        Completed
        • MDS
        • +2 more
        • Scottsdale, Arizona
        • +15 more
        Apr 16, 2021